FDA Investigator Wenzheng Zhang
Wenzheng Zhang has inspections in 3 countries as of 27 Oct 2023. Wenzheng Zhang has collaborated with a combined 1170 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
China,
India
Co-Investigator(s):
Alan P Kurtzberg,
Anita Narula, PhD,
Art O Czabaniuk,
Ashley J Allen Gaines,
Benjamin J Smith,
Bichsa T Tran,
Bowman,
Caroline H Le,
Cheryl A Clausen,
Christopher R Czajka,
Claudia Mperez Kasmarski,
Constantin Y Philopoulos,
David A Paterson,
Diane Cvan Leeuwen,
Dipesh K Shah,
Dogbeda F Mackenzie,
Eileen A Liu,
Emest F Bizjak,
Francisco,
George G Calafactor,
Hung H Do, MS,
James C Maclaughlin,
Jeffery A Hangartner,
Jeffrey A Sommers,
Jennifer M Gogley,
Joanne E King,
Joey V Quitania,
Jolanna A Norton,
Joseph R Strelnik,
Julianne C Mccullough,
Katherine Szestypalow,
Kathy Chiu,
Kathy Kuo,
Kelley,
Kelvin X Sanders,
Khoa Nathanv Tran,
Lance A Finnical,
Larry K Austin,
Laurimer Kuilan Torres,
Liming Zhang,
Linda Thai,
Lixia Cai,
Luis M Burgos Medero,
Mamta Gautam Basak, PhD,
Marijo B Kambere, PhD,
Maxyne T Lam,
Meisha R Sampson,
Meisha Waters,
Peter E Baker,
Rajiv R Srivastava,
Ralph A Erickson,
Richmond K Yip,
Robert M Barbosa,
Rocio Guzman Velazquez,
Roger F Zabinski,
Rumany C Penn, PharmD,
S Lori Brown, PhD MPH,
Saleem A Akhtar,
Santiago Gallardo Johnson,
Sarah A Hassas,
Shirley J Berryman,
State Agency,
Taichun Qin, PhD,
Walden H Lee,
Zachary A Bogorad
Wenzheng Zhang's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2022 | FDA 483 | Dr. J Skinclinic, Inc - Form 483, 2022-03-17 |
December, 2022 | FDA 483 | Sugar Foods Corporation - Form 483, 2022-12-13 |
June, 2023 | FDA 483 | Ipca Laboratories Limited - Form 483, 2023-06-23 |
June, 2023 | FDA 483 | Ipca Laboratories Limited - Form 483, 2023-06-13 |
December, 2019 | FDA 483 | Tianjin Asymchem Pharmaceuticals Co., Ltd. - Form 483, 2019-12-06 |
June, 2021 | FDA 483 | Sanitor Corporation - Form 483, 2021-06-03 |
March, 2023 | FDA 483 | Coastal Contract Packaging, Inc. - Form 483, 2023-03-17 |
August, 2022 | FDA 483 | Azzur Labs - San Diego LLC - Form 483, 2022-08-19 |
September, 2023 | FDA 483 | Nitto Avecia Pharma Services, Inc. - Form 483, 2023-09-22 |
October, 2023 | FDA 483 | Applied Laboratories, Inc. - Form 483, 2023-10-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more